About LIA Diagnostics
LIA Diagnostics is a company based in Philadelphia (United States) founded in 2015. LIA Diagnostics has raised $4.22 million across 4 funding rounds from investors including The Pink Ceiling, Ben Franklin Technology Partners and Robin Hood Ventures. LIA Diagnostics operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, Confer Health, adyn and Jiabao, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lia Diagnostics Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.22 M (USD)
in 4 rounds
-
Latest Funding Round
$2.6 M (USD), Seed
Nov 06, 2018
-
Investors
The Pink Ceiling
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LIA Diagnostics
LIA Diagnostics has successfully raised a total of $4.22M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.6 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LIA Diagnostics
LIA Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include The Pink Ceiling, Ben Franklin Technology Partners and Robin Hood Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in high-growth startups by this group.
|
Locked | Locked | Locked | |
|
Startup accelerator
|
Locked | Locked | Locked |
Investor details for LIA Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LIA Diagnostics
Investment portfolio details for LIA Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LIA Diagnostics
Detailed financials for LIA Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lia Diagnostics Comparisons
Peer comparison for LIA Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LIA Diagnostics
LIA Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, Confer Health, adyn and Jiabao, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fertility decisions are optimized using data analytics and genomics.
|
|
| Locked | Locked | Locked |
Diagnostics and prognostics for maternal health are developed using metabolomics.
|
|
| Locked | Locked | Locked |
Clinical-grade diagnostic tests for home use are developed.
|
|
| Locked | Locked | Locked |
Provider of DNA and hormone analysis based birth control optimization kits
|
|
| Locked | Locked | Locked |
Next-generation sequencing services for assisted reproduction are integrated.
|
Detailed competitors of LIA Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lia Diagnostics
Complete news archive for LIA Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LIA Diagnostics
LIA Diagnostics was founded in 2015.
LIA Diagnostics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
LIA Diagnostics is a funded company, having raised a total of $4.22M across 4 funding rounds to date.
LIA Diagnostics develops paper pregnancy tests that are foldable and disposable. This addresses the challenges surrounding privacy, usability, and sustainability in current at-home diagnostics.It claims that the product is scheduled to go on sale in 2016-17. LIA Diagnostics won the Innovative Idea Competition award at Temple university in 2015.
LIA Diagnostics's top competitors include Celmatix, Metabolomic Diagnostics and adyn.
LIA Diagnostics has 4 investors. Key investors include The Pink Ceiling, Ben Franklin Technology Partners, Robin Hood Ventures, and Dreamit.